Stem Cell Regenerative Program

For years ROCK Institute has referred clients to California Stem Cell Treatment Center, where they provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment.

The Center utilizes a fat transfer surgical technology to isolate and implant the patient’s own stem cells from a small quantity of fat harvested by liposuction on the same day. Patients who seek care at the California Stem Cell Treatment Center are evaluated by a respective member of our multispecialty expert panel of Board Certified physicians representing many medical fields. The California Stem Cell Treatment Center emphasizes quality and is highly committed to clinical research and the advancement of regenerative medicine.

CSCTC was founded in 2010 for the investigational use of stem cells deployments for degenerative conditions. The source of the cells is actually stromal vascular fraction which is a protein rich segment of processed adipose tissue. Stromal vascular fraction contains a mononuclear cell line (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important growth factors that turn on the stem cells and promote their activity. We have high numbers of viable cells and we are trying to learn which diseases respond best and which deployment methods are most effective. We are growing and continue to use our surgical methods to deploy SVF for various degenerative conditions. CSCTC employs a clinical research coordinator to protect our valuable data and our vision is to perfect our treatments and ultimately teach them to other physicians around the world.

California Stem Cell (Cell Surgical Network) Technology

The Cell Surgical Network uses adipose derived stem cells for deployment & clinical research. Early stem cell research has traditionally been associated with the controversial use of embryonic stem cells. The new focus is on non-embryonic adult mesenchymal stem cells which are found in a person’s own blood, bone marrow, and fat. Cell therapy around the world is shifting its focus from bone marrow based cells to adipose (fat) derived cells since the cells are easy to obtain and generally very robust. Adipose fat is an abundant and reliable source of stem cells.

The best quality adipose cells are derived from the enzymatic digestion of liposuctioned fat which can be performed at the bedside in an essentially closed system to protect sterility. Autologous stem cells from a person’s own fat are easy to harvest safely under local anesthesia and are abundant in quantities up to 2500 times those seen in bone marrow.
Clinical success and favorable outcomes appear to be related directly to the quantity of stem cells deployed. Once these adipose derived stem cells are administered back in to the patient, they have the potential to repair human tissue by influencing healing and also forming new cells of mesenchymal origin, such as cartilage, bone, ligaments, tendons, nerve, fat, muscle, blood vessels, and certain internal organs. Stem cells’ ability to form cartilage and bone makes them potentially highly effective in the treatment of degenerative orthopedic conditions. Their ability to form new blood vessels and other tissues makes them suitable for mitigating a large number of traumatic and degenerative conditions.

We have anecdotal and experimental evidence that stem cell therapy is effective in healing and regeneration. Stem cells seek out damaged tissues in order to repair the body naturally. The literature and internet is full of successful testimonials but we are still awaiting definitive studies demonstrating efficacy of stem cell therapy. Such data may take five or ten years to accumulate. In an effort to provide relief for patients suffering from certain degenerative diseases that have been resistant to common modalities of treatment, we have initiated pilot studies as investigational tests of treatment effectiveness with very high numbers of adipose derived stem cells obtained from fat.

The Cell Surgical Network’s cell harvesting and isolation techniques are based on technology from South Korea. This technological breakthrough allows patients to safely receive their own autologous stem cells in extremely large quantities. Our treatments and research are patient funded and we have endeavored successfully to make it affordable. All of our sterile procedures are non-invasive and done under local anesthesia. Patients who are looking for non-surgical alternatives to their degenerative disorders can participate in our trials by filling out our treatment application to determine if they are candidates. The Cell Surgical Network is proud to be state of the art in the new field of Regenerative Medicine.